Home › Blog › Why Pharmacy Working-Capital Loans Get Rejected — and the Records That Fix It

Why Pharmacy Working-Capital Loans Get Rejected — and the Records That Fix It

2026-08-25 • 6 min read

Picture a pharmacist who walks into a bank branch with three years of GST returns and a handwritten stock ledger, needing ₹8 lakh in working capital — enough to stock a second refrigeration unit and pre-pay for a high-margin OTC line before the monsoon season. The loan officer looks at the paperwork for a few minutes and asks them to come back with "proper financial records." They leave without the loan, without a definition of "proper," and without the ₹8 lakh needed to grow.

That scene is easy to imagine in any town, large or small. The bank is not being unreasonable. The pharmacist is not incompetent. The problem is a specific, fixable gap between the records a retail pharmacy naturally produces and the records a lender needs to release funds. If you are reading this because your pharmacy business loan India application stalled, or you are about to apply and do not want to be turned away, this post is about that gap.

What you stand to lose by ignoring this: every month of delay on a working capital line costs you interest on the costlier short-term credit you use as a substitute — money that leaves your account quietly, month after month.

---

Free tools for Indian pharmacies — check a medicine's Schedule (H1/H/X), look up its HSN code and GST rate, or search more than 2.5 lakh medicines. No signup, no account.

Open the free pharmacy tools →

The Cash-Flow Statement Problem: Lenders Cannot See What You Actually Earn

A neighborhood pharmacy in Thane may bill ₹2.5 lakh a month and collect nearly all of it in cash. On paper, it looks like a healthy operation. But when the loan officer asks for a monthly cash-flow statement showing inflows, outflows, and net position across twelve months, many pharmacy owners hand over a GST summary and a printout from a billing software that was not designed to produce that view.

Lenders assessing pharmacy cash flow records want to see three things: consistent revenue month-over-month, low exposure to unpaid credit (distributor or institutional), and a gross margin that holds steady enough to service a new EMI. A GST return tells them revenue. It does not tell them gross margin by category, or how much of that revenue sat in credit for 30 days before collection.

When that data is missing or must be manually assembled from multiple notebooks and spreadsheets, the loan officer marks the file "incomplete documentation" — not "rejected," which means no formal appeal, no clear next step, and another three-month wait.

The annual cost of this gap: if a pharmacy delays a working-capital facility by six months due to documentation issues and bridges that period with costlier short-term credit, the difference in interest is money it never gets back. That is before accounting for the inventory opportunity missed.

---

The Schedule H1 Register: A Regulatory Record That Doubles as a Credit Signal

Under Rule 65(3)(h) of the Drugs and Cosmetics Rules, every retail pharmacy must enter each Schedule H1 supply in a separate register — the prescriber's name and address, the patient's name, the drug and its quantity — kept for three years. Selling a Schedule H1 drug without a prescription is punishable under Section 27(d) of the Drugs and Cosmetics Act, 1940: imprisonment of one to two years and a fine of not less than ₹20,000.

Many pharmacies keep this register. Few keep it in a format that is queryable. When a lender or a CA preparing your financials needs to cross-reference Schedule H1 dispensing volumes against revenue, a handwritten register produces days of manual reconciliation work, not a printout.

The risk here is not just the penalty. It is that the register, properly maintained digitally, is evidence of a high-value prescription customer base with recurring dispensing patterns. That is a credit signal. A lender who can see that a meaningful share of monthly revenue comes from repeat Schedule H1 prescriptions is looking at predictable, recurring income — the kind of income that justifies a working-capital facility. A handwritten register in a drawer communicates none of that.

---

GST 5% on Medicines and the Margin Documentation Gap

Since 22 September 2025, after the 56th GST Council meeting, most medicines classified under HSN 3004 attract GST at 5%. For a pharmacy billing ₹3 lakh a month, that is ₹15,000 in GST collected — and, depending on the input tax credit position, a net GST outflow that must be reconciled monthly.

The documentation problem this creates for medical store working capital applications is subtle but real. Lenders look at net margin after tax. If your GST input credits are not being captured correctly — because your billing software is not tagging purchases against the right HSN codes — your reported margin looks thinner than it is. A pharmacy earning a genuine 18% gross margin on medicines may show 14% on paper because ITC is being left on the table.

That is how a pharmacy loan file comes back with a request for "clarification on margins." Two other reasons are expiry write-offs that appear as unexplained inventory shrinkage, and credit sales to institutions that show as revenue but have not been collected.

---

What the Records Look Like When This Is Solved

The difference between a pharmacy that gets the loan and one that does not is rarely the underlying business. It is the documentation.

What lenders ask forWhat many pharmacies produceWhat a well-documented pharmacy produces
12-month cash-flow statementGST summary + billing printoutMonth-by-month P&L with category margins
Inventory valuation with expiry agingPhysical count + rough estimateFEFO-sorted batch list, expiry buckets, write-off log
Schedule H1 compliance recordHandwritten registerLogged at billing, not written up later
Gross margin by product categoryNot availableAuto-generated from purchase vs. billing data
GST ITC reconciliationManually preparedAuto-matched against GSTR-2B

Now picture that same pharmacist walking into the bank a second time — this time with a twelve-month P&L by category, a Schedule H1 log written at billing, and an expiry write-off log that explains every rupee of inventory shrinkage. The four-minute review becomes a forty-minute conversation, and the working-capital facility has a real chance of approval instead of deferral.

---

What Nesayo Puts in Your Hands Before That Loan Meeting

Picture a pharmacy running Nesayo in the months before a loan application. Every bill carries its HSN code and GST, and the P&L, the day book and the GST summaries are built from those same bills — so the numbers a CA pulls for a loan file come from one place. On the Full plan, the Morning Briefing puts yesterday's picture — stock running low, batches entering the expiry windows, bills past their due date — on a phone screen before the shutter is up.

FEFO batch selection at billing sells the earliest-expiring batch first, and on the Full plan Expiry Guard suggests a discount or a return for near-expiry stock, so the inventory valuation a CA pulls shows current stock value, not a number inflated by batches that should have been returned months ago. Credit sales stay marked pending until they are paid, so the cash-flow picture shows collections that actually happened, not receivables that have silently turned bad. Payment Advisor watches the other side: the distributor payments falling due.

Schedule H1 sales are logged automatically at billing: date, medicine, batch, quantity and bill number, with the patient and prescriber names entered on the bill. Nesayo does not record the prescriber's address yet, so the pharmacist adds it to complete the Rule 65(3)(h) register. The catalogue of more than 2.5 lakh medicines carries a schedule flag for each listed medicine, so H1 lines are flagged at the point of dispensing rather than reconstructed from memory at month-end.

Nesayo's billing is free forever (see current plan details at nesayo.com/pricing). As of October 2026 (pricing at nesayo.com/pricing), the Essential plan is ₹249 per month (voice billing, prescription scanning and Refill Radar), and the Full plan is ₹549 per month for all five agents, including Payment Advisor and Expiry Guard.

---

The Choice, and What Happens Next

If you do nothing, the records problem does not fix itself. The next loan application will go to the same officer with the same file, and the outcome will be the same. The short-term credit will keep costing more than a working-capital line would. The expiry write-offs will keep appearing as unexplained shrinkage. The Schedule H1 register will stay in a drawer.

Or you spend two minutes at nesayo.com/demo — a sample pharmacy is pre-loaded, no signup required. Look at the reports — the P&L, the day book, the GST summaries — and what they look like when every bill is already in the system. Then decide whether your next loan meeting goes the way that first meeting went, or the way the second one did.

---

FAQ

Will migrating to a new system mean I lose my old billing data or face weeks of downtime?

Nesayo imports your stock from CSV or Excel exports — which most billing software, including Marg (per publicly listed features on Marg's website as of April 2026), can produce — and our team will move your data across for you, free (file and photo imports run during your free first month of Full, or on a paid plan). The PWA offline billing means the counter keeps running even during the setup period. Your old data does not disappear: keep it for the months before you switched, while Nesayo's reports build from every bill you raise after.

What if my staff is not comfortable with new software, or the internet goes down mid-billing?

On the paid plans, Nesayo supports voice billing (beta) in Hindi and English, so a staff member who is faster speaking than typing can bill by voice without retraining. For connectivity gaps — which are common in smaller towns — Nesayo's PWA architecture allows offline billing. Transactions sync when the connection returns — keep the billing page open until it does — and the counter does not stop.

The billing is free — what is the catch, and can I actually trust AI to prepare records for a loan file?

The billing module is free because Nesayo's business model is the AI agent subscriptions, not the billing software. There is no catch in the sense of hidden fees or feature locks on core billing. On the AI and loan records question: the agents do not prepare your loan file — your CA does that. What Nesayo does is keep structured, queryable data — every bill with its HSN and GST, the P&L and day book built from those bills, the Schedule H1 log, expiry aging, purchase records — that your CA can work from much faster than from notebooks. The accuracy depends on what is billed through Nesayo: what goes in is what comes out. The more complete your billing data, the cleaner the output your CA sees.

Nesayo runs pharmacy operations while you serve customers

Free billing forever. Full — 5 agents, voice billing in Hindi — is ₹549/month (as of October 2026). Every new standalone pharmacy gets 1 month of Full free from signup, with no card. Manual billing and manual stock stay free forever.

Start free →